SCHEMBL14033167

SCHEMBL14033167

NC(=O)CCNC(=O)c1cnn2cc(Cc3ccc(Cl)c(Cl)c3)cnc12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 4/20 0.41
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LIPC P11150 1/20 0.38
LIPG Q9Y5X9 1/20 0.38
IRAK4 Q9NWZ3 7/20 0.38
CHEK1 O14757 1/20 0.36
CHEK2 O96017 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
RORC P51449 1/20 0.35
MAPT P10636 1/20 0.35
HKDC1 Q2TB90 1/20 0.35
TEAD2 Q15562 1/20 0.35
IRAK1 P51617 1/20 0.35
MALT1 Q9UDY8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033706 0.92 GPR52 (0.41) PDE2AKDM4EPKMHSD17B10IRAK4
SCHEMBL14033169 0.90 PDE2A (0.42) PDE2AKDM4EPKMHSD17B10LIPC
SCHEMBL4439128 0.88 PDE2A (0.48) PDE2AKDM4EPKMHSD17B10IRAK4
SCHEMBL14048912 0.87 PDE2A (0.44) PDE2AKDM4EPKMHSD17B10LIPC
SCHEMBL4555125 0.87 IRAK4 (0.43) PDE2AKDM4EPKMHSD17B10LIPC
SCHEMBL14032998 0.85 PDE2A (0.43) PDE2AKDM4EPKMHSD17B10LIPC
SCHEMBL4553722 0.85 IRAK4 (0.43) PDE2AKDM4EPKMHSD17B10LIPC
SCHEMBL14033688 0.85 PDE2A (0.46) PDE2AKDM4ELIPCLIPGIRAK4
SCHEMBL14033170 0.85 MAPK1 (0.42) PDE2AKDM4EPKMHSD17B10LIPC
SCHEMBL14033330 0.84 PDE2A (0.41) PDE2AKDM4EPKMHSD17B10LIPC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255153-A1 New compounds SCD, SCD5, FADS2 PDE2A 2511/4885KDM4E 1192/4885PKM 937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.